1st Quarter - Report

AVENUE SOLUTIONS for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to payment policies for non-opioid pain medication; Issues related to Medicaid access for people living with Sickle Cell Disease; Senate Finance Committees Better Mental Health Care, Lower Cost Drugs and Extenders Act (Discussion Draft); S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act; Issues related to Medicaid Drug Rebate Program

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
JORDAN A LACROSSE —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2973 (118th), H.R. 5378 (118th)

Health Issues HCR

Expiring healthcare extenders; S. 1339, Pharmacy Benefit Manager Reform Act; Issues related to 340b; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
JORDAN A LACROSSE —
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4366 (118th), H.R. 2882 (118th), S. 1339 (118th)

Homeland Security HOM

Issues related to biosecurity

LobbyistCovered position, as disclosed
JORDAN A LACROSSE —
TRACY SPICER —

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.